{"disease":{"id":"hemodialysis-chronic-kidney-disease-patients-with-anemia","name":"hemodialysis chronic kidney disease patients with anemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02952092","title":"A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02780141","title":"A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}